Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.23.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2023
Jun. 30, 2022
Assets:    
Cash and cash equivalents $ 52,749 $ 80,485
Accounts receivable 4,247 3,793
Inventory 7,558 4,094
Other current assets 3,665 3,359
Total current assets 68,219 91,731
Property and equipment, net 57,313 51,157
Goodwill 14,530 8,051
Intangibles, net 15,889 8,994
Operating lease right-of-use asset, net 1,483 1,126
Other assets 71 279
Total Assets 157,505 161,338
Current Liabilities:    
Accounts payable and accrued expenses 11,270 11,204
Contingent consideration 8 855
Deferred revenue 114 286
Operating lease liability 415 313
Total current liabilities 11,807 12,658
Long-term Liabilities:    
Convertible notes payable, net 43,696 43,731
Promissory notes payable 333
Contingent consideration 591
Operating lease liability 1,093 811
Other long-term liabilities 117 117
Total long-term liabilities 45,239 45,250
Total Liabilities 57,046 57,908
Stockholders’ Equity    
Preferred stock, par value $0.001: 5,000,000 shares authorized; none issued and outstanding
Common stock, $0.001 par value; 125,000,000 shares authorized; 71,625,149, and 57,079,347 shares issued and outstanding at March 31, 2023 and June 30, 2022, respectively 72 57
Additional paid in capital 352,977 310,171
Accumulated deficit (252,590) (206,798)
Total Stockholders’ Equity 100,459 103,430
Total Liabilities and Stockholders’ Equity $ 157,505 $ 161,338